U.S. Genomics Announces Recipient of Outstanding Investigator in Single Molecule Biology Award
News Feb 21, 2006
U.S. Genomics has announced that Dr. James A. Spudich of Stanford University is the recipient of the Company's first annual award for Outstanding Investigator Single Molecule Biology Award.
The award will be presented at the 50th Annual Meeting of the Biophysical Society in Salt Lake City, Utah.
The Biophysical Society Awards Program honors its members by recognizing excellence in biophysics and promoting interaction among life scientists throughout the world.
"Biology happens at the molecular level. Dr. Spudich's research achievements with myosin demonstrate the importance of working at the level of single molecules to discover the basis of fundamental cellular processes," said John J. Canepa, CEO of U.S. Genomics.
"As the pioneer of single molecule biology tools, U.S. Genomics is proud to sponsor an award that recognizes and promotes outstanding contributions in this field. The Biophysical Society Annual Meeting offers a premier venue in which to acknowledge Dr. Spudich's great achievements."
"The Biophysical Society is pleased to recognize Dr. Spudich's longstanding efforts to further the study of the molecular basis of cell motility through single molecule approaches," said Steven M. Block, President of the Biophysical Society.
"U.S. Genomics' award will encourage future exploration and acknowledge excellence in this advanced area of biophysics research."
Over 130 Glaucoma Gene Variants Could Help Predict BlindnessNews
An international study has identified 133 genetic variants that could help predict the risk of developing glaucoma, the world’s leading cause of incurable blindness. The findings are an advance in the fight to tackle the incurable, degenerative condition, which has virtually no symptoms in the early stages, and could lead to a genetic-based screening program.READ MORE
Yeast Study Performs Hundreds of Simultaneous CRISPR EditsNews
A new technique which can alter hundreds of different genes at once in baker's yeast could greatly speed up CRISPR-Cas9 editing and offer a way to perform high-throughput functional genomics.READ MORE
Cell Types Underlying Schizophrenia IdentifiedNews
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.READ MORE